The changing reimbursement landscape is one of the most important challenges being faced by the healthcare industry. If not addressed effectively, it will continue to be an issue and be a detriment to not only industry, but also patient care. In this presentation Stephanie Ibbotson endeavors to provide some examples for how companies can develop products that can withstand market constraints, and provide value for customers, helping to mitigate the risks of negative reimbursement changes.
From this presentation, the audience will gain a new perspective on how to work within the constraints of the reimbursement market. Examples of different models will demonstrate how using flexible cost models and clinical utility can drive towards value-based reimbursement.
About the Speaker:
Stephanie Ibbotson heads the Health Policy and Reimbursement Affairs department at Luminex Corporation. Stephanie joined Luminex in 2015 and was involved in Marketing strategy and product commercialization prior to taking on her current role. Stephanie is passionate about healthcare reform and is focused on building clinical utility evidence for syndromic assays to achieve value-based reimbursement coverage.
Event Sponsored by: Lee & Hayes, leehayes.com